STOCK TITAN

T2 Biosystems (TTOO) Stock Price, News & Analysis

TTOO OTC Link

Company Description

T2 Biosystems (OTC Link: TTOO) is classified in the diagnostics & research industry within the Surgical & Medical Instruments & Apparatus sector.

TTOO has declined 97.7% over the past year. Shares last traded at $0.0005.

For FY2023, T2 Biosystems reported revenue of $7.2M with net income of -$50.1M and diluted earnings per share of -$19.19. The company operates at a net profit margin of -696.2%.

This page collects what Stock Titan holds for TTOO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-97.7%
Performance 1 year

T2 Biosystems (TTOO) stock last closed at $0.0005. Over the past 12 months, the stock has lost 97.7%.

See what a $1,000 investment in TTOO would be worth today

TTOO Rankings

Market Cap
$2.4M
#7,149

SEC Filings

T2 Biosystems has filed 1 recent SEC filing, including 1 Form 25-NSE. The most recent filing was submitted on July 10, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TTOO SEC filings →

Financial Highlights

T2 Biosystems generated $7.2M in revenue in FY2023, operating income reached -$49.7M (-690.4% operating margin), and net income was -$50.1M, reflecting a -696.2% net profit margin. Diluted earnings per share stood at -$19.19. The company generated -$48.1M in operating cash flow. With a current ratio of 0.45, short-term liquidity bears monitoring.

$7.2M
Revenue (FY2023)
-$50.1M
Net Income (FY2023)
-$48.1M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in T2 Biosystems (TTOO) currently stands at 4.9 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for T2 Biosystems (TTOO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.5 days.

TTOO Company Profile & Sector Positioning

T2 Biosystems (TTOO) operates in the Diagnostics & Research industry within the broader Surgical & Medical Instruments & Apparatus sector and is listed on the OTC Link.

Investors comparing TTOO often look at related companies in the same sector, including Rushnet Inc (RSHN), Identa Ltd Rvice (IDTA), Interpace Biosciences Inc (IDXG), Invitro Internat (IVRO), and Angle Plc Surrey (ANPCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TTOO's relative position within its industry.

Frequently Asked Questions

What is the current stock price of T2 Biosystems (TTOO)?

The current stock price of T2 Biosystems (TTOO) is $0.0005 as of August 17, 2026.

What is the revenue of T2 Biosystems (TTOO) stock?

The FY2023 revenue of T2 Biosystems (TTOO) is $7.2M, from its most recent completed fiscal year.

What is the net income of T2 Biosystems (TTOO)?

The FY2023 net income of T2 Biosystems (TTOO) is -$50.1M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of T2 Biosystems (TTOO)?

The diluted earnings per share (EPS) of T2 Biosystems (TTOO) is -$19.19 for FY2023, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of T2 Biosystems (TTOO)?

The operating cash flow of T2 Biosystems (TTOO) is -$48.1M. Learn about cash flow.

What is the profit margin of T2 Biosystems (TTOO)?

The net profit margin of T2 Biosystems (TTOO) is -696.2%. Learn about profit margins.

What is the operating margin of T2 Biosystems (TTOO)?

The operating profit margin of T2 Biosystems (TTOO) is -690.4%. Learn about operating margins.

What is the current ratio of T2 Biosystems (TTOO)?

The current ratio of T2 Biosystems (TTOO) is 0.45, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of T2 Biosystems (TTOO)?

The operating income of T2 Biosystems (TTOO) is -$49.7M. Learn about operating income.